Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

247 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The CONVINCE randomized trial found positive effects on quality of life for patients with chronic kidney disease treated with hemodiafiltration.
Rose M, Fischer FH, Liegl G, Strippoli GFM, Hockham C, Vernooij RWM, Barth C, Canaud B, Covic A, Cromm K, Cucui AM, Davenport A, Fischer KI, Hegbrant J, Jaha H, Schappert A, Török M, Woodward M, Bots ML, Blankestijn PJ; CONVINCE Scientific Committee and CONVINCE Investigators. Rose M, et al. Among authors: strippoli gfm. Kidney Int. 2024 Nov;106(5):961-971. doi: 10.1016/j.kint.2024.07.014. Epub 2024 Jul 30. Kidney Int. 2024. PMID: 39089577 Free article. Clinical Trial.
Physical performance tasks were linked to the PROMIS physical function metric in patients undergoing hemodialysis.
Liegl G, Fischer FH, Woodward M, Török M, Strippoli GFM, Hegbrant J, Davenport A, Cromm K, Canaud B, Bots ML, Blankestijn PJ, Barth C, Fischer KI, Rose M. Liegl G, et al. Among authors: strippoli gfm. J Clin Epidemiol. 2023 Jul;159:128-138. doi: 10.1016/j.jclinepi.2023.04.007. Epub 2023 Apr 25. J Clin Epidemiol. 2023. PMID: 37105321 Free PMC article.
Effect of Hemodiafiltration or Hemodialysis on Mortality in Kidney Failure.
Blankestijn PJ, Vernooij RWM, Hockham C, Strippoli GFM, Canaud B, Hegbrant J, Barth C, Covic A, Cromm K, Cucui A, Davenport A, Rose M, Török M, Woodward M, Bots ML; CONVINCE Scientific Committee Investigators. Blankestijn PJ, et al. Among authors: strippoli gfm. N Engl J Med. 2023 Aug 24;389(8):700-709. doi: 10.1056/NEJMoa2304820. Epub 2023 Jun 16. N Engl J Med. 2023. PMID: 37326323 Clinical Trial.
High-Target Hemodiafiltration Convective Dose Achieved in Most Patients in a 6-Month Intermediary Analysis of the CONVINCE Randomized Controlled Trial.
Vernooij RWM, Hockham C, Barth C, Canaud B, Cromm K, Davenport A, Hegbrant J, Rose M, Strippoli GFM, Török M, Woodward M, Bots ML, Blankestijn PJ. Vernooij RWM, et al. Among authors: strippoli gfm. Kidney Int Rep. 2023 Aug 19;8(11):2276-2283. doi: 10.1016/j.ekir.2023.08.004. eCollection 2023 Nov. Kidney Int Rep. 2023. PMID: 38025213 Free PMC article.
Using a measurement type-independent metric to compare patterns of determinants between patient-reported versus performance-based physical function in hemodialysis patients.
Liegl G, Fischer FH, Canaud B, Woodward M, Barth C, Davenport A, Török M, Strippoli GFM, Hegbrant J, Cromm K, Bots ML, Blankestijn PJ, Fischer KI, Rose M; CONVINCE Scientific Committee. Liegl G, et al. Among authors: strippoli gfm. Qual Life Res. 2024 Nov;33(11):2987-3001. doi: 10.1007/s11136-024-03745-6. Epub 2024 Aug 5. Qual Life Res. 2024. PMID: 39103575 Free PMC article. Clinical Trial.
Psychosocial Determinants for Self-Reported Health Status in Hemodialysis Patients: A Cohort Analysis of the CONVINCE Randomized Trial.
Cromm K, Ngoc Pham LH, Jaha H, Fischer KI, Liegl G, Schappert A, Davenport A, Barth C, Blankestijn PJ, Hegbrant J, Fischer FH, Strippoli GFM, Rose M; CONVINCE Scientific Committee and Investigators. Cromm K, et al. Among authors: strippoli gfm. Kidney360. 2024 Oct 2. doi: 10.34067/KID.0000000599. Online ahead of print. Kidney360. 2024. PMID: 39356555 Free article.
Haemodiafiltration versus haemodialysis for kidney failure: an individual patient data meta-analysis of randomised controlled trials.
Vernooij RWM, Hockham C, Strippoli G, Green S, Hegbrant J, Davenport A, Barth C, Canaud B, Woodward M, Blankestijn PJ, Bots ML; CONVINCE Scientific Committee; HDF Pooling Project Investigators. Vernooij RWM, et al. Lancet. 2024 Oct 25:S0140-6736(24)01859-2. doi: 10.1016/S0140-6736(24)01859-2. Online ahead of print. Lancet. 2024. PMID: 39489903
Capacity for the management of kidney failure in the International Society of Nephrology Western Europe region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA).
Pippias M, Alfano G, Kelly DM, Soler MJ, De Chiara L, Olanrewaju TO, Arruebo S, Bello AK, Caskey FJ, Damster S, Donner JA, Jha V, Johnson DW, Levin A, Malik C, Nangaku M, Okpechi IG, Tonelli M, Ye F, Coppo R, Lightstone L; Regional Board and ISN-GKHA Team Authors. Pippias M, et al. Kidney Int Suppl (2011). 2024 Apr;13(1):136-151. doi: 10.1016/j.kisu.2024.01.008. Epub 2024 Apr 8. Kidney Int Suppl (2011). 2024. PMID: 38618502 Free PMC article. Review.
Effects of the dose of erythropoiesis stimulating agents on cardiovascular events, quality of life, and health-related costs in hemodialysis patients: the clinical evaluation of the dose of erythropoietins (C.E. DOSE) trial protocol.
Strippoli GF; Clinical Evaluation of the DOse of Erythropoietins Study Group (C.E. DOSE). Strippoli GF, et al. Trials. 2010 Jun 9;11:70. doi: 10.1186/1745-6215-11-70. Trials. 2010. PMID: 20534124 Free PMC article. Clinical Trial.
247 results